CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study
CRAFITY评分作为肝细胞癌患者对阿特珠单抗联合贝伐珠单抗治疗耐药性的预测指标:一项多中心回顾性研究
期刊:Journal of Gastroenterology
影响因子:5.5
doi:10.1007/s00535-024-02150-7
Ueno, Masayuki; Takeda, Haruhiko; Takai, Atsushi; Morimura, Hiroki; Nishijima, Norihiro; Iwamoto, Satoru; Okuyama, Shunsuke; Umeda, Makoto; Seta, Takeshi; Ikeda, Atsuyuki; Goto, Tomoyuki; Miyamoto, Shin'ichi; Kayahara, Takahisa; Uenoyama, Yoshito; Matsumura, Kazuyoshi; Nakano, Shigeharu; Mishima, Masako; Inuzuka, Tadashi; Eso, Yuji; Takahashi, Ken; Marusawa, Hiroyuki; Osaki, Yukio; Hatano, Etsuro; Seno, Hiroshi